🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire, Amiens
NCT06815107 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patient over 18 years old * patient who need Ureteral Double-J Stenting Exclusion Criteria: * patient under 18 years old, * Iterative change, * understanding disorder, * inability to answer the questionnaire, * refusal of the patient, * long-term Ureteral Double-J Stenting (more than 6 month), * active cancer.
💊

What it tests

  • questionnary
  • USSQ survey
📍

Where

1 site
CHU Amiens-Picardie
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy